CopyMark Law Group
4.9/5
Drawing for LENIOBIO

USPTO serial 88080476

LENIOBIO

Reviewed by CopyMark Law Group

Reg. 5785600Status 702Registered
Filing date
Status date
Registration date
Jun 25, 2019
Examiner
EULIN, INGRID C
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with LENIOBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew A. Homyk

Matthew A. Homyk BLANK ROME LLPONE LOGAN SQUARE8th FloorPHILADELPHIA, PA 19103

Goods and services

ClassDescriptionStatusFirst use
001Enzymes for technical use, namely, enzymes for scientific and research purposes; enzymes for scientific purposes; enzymes for industrial purposes; enzymes for use in the food industry for food or drinks; and kits for manufacturing proteins comprised primarily of chemicals, nucleic acids, unprocessed synthetic resins, chemical reagents for non-medical purposes, tobacco extracts, purification supports, plasmids, hormones, cells, gels, buffers, and stains, all for laboratory or research useACTIVE—
005Enzymes for medical purposes, pharmaceutical purposes and veterinary purposesACTIVE—
040Custom made manufacturing of proteins using scientific processesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 18, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 18, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 18, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 17, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Jun 25, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 25, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 20, 2019DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
May 20, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 6, 2019IUCNNOTICE OF ALLOWANCE CANCELLED—
May 6, 2019EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Apr 30, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 5, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 5, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 13, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 30, 2019FIXDELECTRONIC RECORD REVIEW COMPLETE—
Jan 25, 2019ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jan 17, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 16, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Jan 16, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 16, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 16, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 13, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 13, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 13, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 3, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 3, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 3, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 3, 2018DOCKASSIGNED TO EXAMINER—
Sep 11, 2018AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Sep 6, 2018ALIEASSIGNED TO LIE—
Aug 24, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 22, 2018PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Aug 20, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance